Cyril Allouche Insider Trading $RVNC Revance Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cyril Allouche.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cyril Allouche. Cyril Allouche is Principal Accounting Officer in Revance Therapeutics, Inc. ($RVNC) and Principal Financial Officer in Revance Therapeutics, Inc. ($RVNC).
Cyril Allouche in Revance Therapeutics, Inc.
Trading Symbol: RVNCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cyril Allouche: Principal Accounting Officer, Principal Financial Officer
Holdings: 6,898 shares
Current Value: $142,789
Latest Transaction: Mar 19 2019
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cyril Allouche in Revance Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Sell | S | 15.48 | 498 | 7,709 | 6,400 | 6.9 K to 6.4 K (-7.22 %) |
Mar 19 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Payment of Exercise | F | 15.45 | 252 | 3,893 | 6,898 | 7.2 K to 6.9 K (-3.52 %) |
Jan 25 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Option Exercise | A | 17.23 | 6,500 | 111,995 | 6,500 | |
Jan 25 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Grant | A | 0.00 | 3,150 | 0 | 7,150 | 4 K to 7.2 K (+78.75 %) |
Jan 23 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Option Exercise | M | 13.35 | 625 | 8,344 | 6,875 | |
Jan 23 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Sell | S | 17.77 | 625 | 11,106 | 4,000 | 4.6 K to 4 K (-13.51 %) |
Jan 23 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Buy | M | 13.35 | 625 | 8,344 | 4,625 | 4 K to 4.6 K (+15.63 %) |
Jan 04 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Sell | S | 19.48 | 375 | 7,305 | 4,000 | 4.4 K to 4 K (-8.57 %) |
Jan 02 2019 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Buy | J | 17.11 | 375 | 6,416 | 4,375 | 4 K to 4.4 K (+9.38 %) |
Nov 21 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Sell | S | 20.66 | 491 | 10,144 | 4,000 | 4.5 K to 4 K (-10.93 %) |
Nov 16 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Payment of Exercise | F | 20.99 | 259 | 5,436 | 4,491 | 4.8 K to 4.5 K (-5.45 %) |
Nov 09 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Option Exercise | M | 13.35 | 2,188 | 29,210 | 7,500 | |
Nov 09 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Sell | S | 23.72 | 2,188 | 51,899 | 4,750 | 6.9 K to 4.8 K (-31.54 %) |
Nov 09 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Buy | M | 13.35 | 2,188 | 29,210 | 6,938 | 4.8 K to 6.9 K (+46.06 %) |
Nov 09 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Option Exercise | M | 13.35 | 2,188 | 29,210 | 7,500 | |
Nov 09 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Sell | S | 23.72 | 2,188 | 51,899 | 4,750 | 6.9 K to 4.8 K (-31.54 %) |
Nov 09 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Accountin ... | Buy | M | 13.35 | 2,188 | 29,210 | 6,938 | 4.8 K to 6.9 K (+46.06 %) |
Jul 06 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Financial ... | Sell | S | 28.35 | 393 | 11,142 | 4,750 | 5.1 K to 4.8 K (-7.64 %) |
Jul 06 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Financial ... | Sell | S | 28.35 | 393 | 11,142 | 4,750 | 5.1 K to 4.8 K (-7.64 %) |
Jul 03 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Financial ... | Buy | J | 23.33 | 393 | 9,170 | 5,143 | 4.8 K to 5.1 K (+8.27 %) |
Jun 22 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Financial ... | Option Exercise | A | 30.75 | 9,500 | 292,125 | 9,500 | |
Jun 22 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Financial ... | Grant | A | 0.00 | 250 | 0 | 4,750 | 4.5 K to 4.8 K (+5.56 %) |
Jun 22 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Financial ... | Option Exercise | A | 30.75 | 9,500 | 292,125 | 9,500 | |
Jun 22 2018 | RVNC | Revance Therapeuti ... | Allouche Cyril | Principal Financial ... | Grant | A | 0.00 | 250 | 0 | 4,750 | 4.5 K to 4.8 K (+5.56 %) |
Page: 1